High Tech Pharm Statistics

Total Valuation

High Tech Pharm has a market cap or net worth of KRW 150.03 billion. The enterprise value is 150.28 billion.

Market Cap	150.03B
Enterprise Value	150.28B

Important Dates

The last earnings date was Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

High Tech Pharm has 10.63 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class	n/a
Shares Outstanding	10.63M
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	5.53%
Owned by Institutions (%)	0.22%
Float	5.84M

Valuation Ratios

The trailing PE ratio is 10.95.

PE Ratio	10.95
Forward PE	n/a
PS Ratio	1.94
PB Ratio	1.25
P/TBV Ratio	1.25
P/FCF Ratio	11.95
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 11.97.

EV / Earnings	10.96
EV / Sales	1.94
EV / EBITDA	7.25
EV / EBIT	9.66
EV / FCF	11.97

Financial Position

The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.07.

Current Ratio	3.39
Quick Ratio	1.48
Debt / Equity	0.07
Debt / EBITDA	0.39
Debt / FCF	0.64
Interest Coverage	19.76

Financial Efficiency

Return on equity (ROE) is 12.09% and return on invested capital (ROIC) is 7.74%.

Return on Equity (ROE)	12.09%
Return on Assets (ROA)	7.07%
Return on Invested Capital (ROIC)	7.74%
Return on Capital Employed (ROCE)	12.84%
Revenue Per Employee	1.19B
Profits Per Employee	210.92M
Employee Count	65
Asset Turnover	0.56
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.15% in the last 52 weeks. The beta is 0.82, so High Tech Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+39.15%
50-Day Moving Average	15,090.40
200-Day Moving Average	15,176.40
Relative Strength Index (RSI)	35.35
Average Volume (20 Days)	40,658

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, High Tech Pharm had revenue of KRW 77.51 billion and earned 13.71 billion in profits. Earnings per share was 1,289.00.

Revenue	77.51B
Gross Profit	19.48B
Operating Income	15.56B
Pretax Income	17.09B
Net Income	13.71B
EBITDA	20.73B
EBIT	15.56B
Earnings Per Share (EPS)	1,289.00

Full Income Statement

Balance Sheet

The company has 7.76 billion in cash and 8.00 billion in debt, giving a net cash position of -243.03 million or -22.86 per share.

Cash & Cash Equivalents	7.76B
Total Debt	8.00B
Net Cash	-243.03M
Net Cash Per Share	-22.86
Equity (Book Value)	119.74B
Book Value Per Share	11,246.36
Working Capital	45.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.69 billion and capital expenditures -2.13 billion, giving a free cash flow of 12.56 billion.

Operating Cash Flow	14.69B
Capital Expenditures	-2.13B
Free Cash Flow	12.56B
FCF Per Share	1,181.04

Full Cash Flow Statement

Margins

Gross margin is 25.13%, with operating and profit margins of 20.07% and 17.69%.

Gross Margin	25.13%
Operating Margin	20.07%
Pretax Margin	22.04%
Profit Margin	17.69%
EBITDA Margin	26.74%
EBIT Margin	20.07%
FCF Margin	16.20%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.71%.

Dividend Per Share	100.00
Dividend Yield	0.71%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	5.17%
Buyback Yield	-0.09%
Shareholder Yield	0.62%
Earnings Yield	9.14%
FCF Yield	8.37%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.5

Scores

High Tech Pharm has an Altman Z-Score of 6.35.

Altman Z-Score	6.35
Piotroski F-Score	n/a